• About Us
  • Board of Advisors
  • Contact

MALARIA.com

A Malaria Information and Community Portal

  • Home
  • Malaria Overview
  • Malaria Research
  • News
  • Videos
  • Blogs
  • Malaria Q&A
  • Events
  • Jobs
Home / Malaria Q&A / Treatment of Malaria in India

Treatment of Malaria in India

January 7, 2012 By Malaria Q&A 2 Comments

QUESTION

In India how to treat a child and adult suffering from malaria?

ANSWER

Chloroquine-resistant malaria has been observed in India and so the first line drug of choice should be an artemisinin-derivative in combination with another drug (this group of medications are more generally known as “artemisinin-based combination therapies” or ACTs). A common example of this is artemether in combination with lumefantrine, which is marketed as Coartem. Coartem is also used to treat malaria in children over 11 pounds (5 kg) in weight.

Filed Under: Malaria Q&A Tagged With: ACTs, artemether, Artemisinin, Chloroquine-Resistant Malaria, Coartem, India, lumefantrine, Malaria Treatment

Comments

  1. dr r satpathy says

    January 12, 2012 at 8:25 pm

    Thanks.
    Malaria in India seems to be a mixed situation now.
    Many parts of the country, still do not have resistant cases to choroquine or quinine.
    In many parts of the country choroquine is now being used to treat Pla.vivax and Pla.falciparum uncomplecated cases. Such mixed situation perhaps needs use of different drug in different area of the country. ACT is expensive , not available at all places and therefore may be second choice in uncomplecated situation.

    Log in to Reply
    • Claire Standley, Editor says

      January 22, 2012 at 2:21 pm

      Thank you for your comments. It is true that the distribution of sensitive versus susceptible malaria is often generally described at country-level, whereas the regional dynamics are usually more subtle. The WHO has recommended ACTs as first line treatment in order to prevent future resistance from emerging, and the Roll Back Malaria initiative, among others, has been very instrumental for providing Coartem to high transmission areas. It is very interesting to hear your success with chloroquine for non-complicated Pf as well as Pv – do you monitor for signs of emerging resistance? Thank you again for visiting the site and sharing your insight on malaria treatment! – Claire

      Log in to Reply

Leave a Reply Cancel reply

You must be logged in to post a comment.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Stay Informed

WWARN Corner

About WWARN

The WorldWide Antimalarial Resistance Network (WWARN) generates innovative resources and reliable evidence to inform the malaria community on the factors affecting the efficacy of antimalarial medicines. Learn more…

  • Fighting Malaria Requires Protecting the Effectiveness of Antimalarial Medicines
  • Data Sharing at IDDO
  • Evidence to inform equitable dosing in very young and malnourished children

More WWARN Stories...

  • Home
  • Malaria Overview
  • Malaria Research
  • News
  • Videos
  • Blogs
  • Malaria Q&A
  • Events
  • Jobs
  • About Us
  • Board of Advisors
  • Contact

Copyright © 2023 Malaria.com ยท Log in